-
公开(公告)号:WO2022240286A1
公开(公告)日:2022-11-17
申请号:PCT/NL2022/050244
申请日:2022-05-04
IPC分类号: A61K38/01 , A61P21/06 , A23L33/00 , A61K31/195 , A23L33/175 , A23L33/19 , A61K31/202 , A23L33/115 , A23L33/12 , A23L33/40 , A61K31/14 , A61K31/19 , A61K31/198 , A61K38/018
摘要: The invention relates to a nutritional composition, comprising, per 100 kcal, - about 5 to 25.0 g of proteinaceous matter, of which - about 5 to 24.9 g of proteinaceous matter derived from milk; wherein - the serine content is at least about 7 wt.%, based on the weight of the proteinaceous matter, and wherein - the glycine content of the nutritional composition is between 5 and 30 wt.%, preferably between 5 and 20 wt. %, more preferably between 5 and 15 wt.% based on the weight of the proteinaceous matter.
-
公开(公告)号:WO2022269050A1
公开(公告)日:2022-12-29
申请号:PCT/EP2022/067380
申请日:2022-06-24
发明人: FASANO, Alessio , GROSS, Gabriele , MANURUNG, Sarmauli Irianti , SENGER, Stefania , VAN TOL, Eric Alexander Franciscus
IPC分类号: A61K38/17 , A61P1/00 , A61P29/00 , A23J1/202 , A23J3/325 , A23J3/344 , A23L33/00 , A23L33/40 , A23V2200/32 , A23V2250/54246 , A61K38/018 , A61K38/1709 , A61K9/14 , A61P37/06 , A61P37/08
摘要: The present application relates to extensively hydrolysed protein, and compositions comprising extensively hydrolysed protein, for use in reducing the risk of intestinal inflammation, reducing the risk of intestinal tissue damage, and/or improving gut barrier function, in an infant.
-
公开(公告)号:WO2021046408A2
公开(公告)日:2021-03-11
申请号:PCT/US2020/049488
申请日:2020-09-04
发明人: COOPER, Jennifer
IPC分类号: A23L19/00 , A23L2/52 , A61K33/24 , A23L33/15 , A23L33/155 , A23L33/16 , A23L33/17 , A61K31/198 , A61K31/702 , A61K33/00 , A61K35/00 , A61K35/54 , A61K36/185 , A61K36/39 , A61K36/45 , A61K36/539 , A61K36/54 , A61K36/73 , A61K36/9066 , A61K38/01 , A61K38/011 , A61K38/012 , A61K38/014 , A61K38/018 , A61K38/54 , A61K45/06
摘要: Provided are dietary supplement composition comprising one or both of theanine and a trace mineral complex, optionally in combination with bioactive peptides, in an amount or amount individually or in combination effective to promote gut health. Examples of benefits include one or more of an increase in the amount of total short-chain fatty acid production or of at least one of propionate, acetate and butyrate; an increase the expression or level of at least one tight-junction protein or mucin-3 or decrease the expression or level of claudin -2; an increase in transepithelial electrical resistance; an increase in the abundance or diversity of a member or phylum of the intestinal bacterial community of the intestinal lumen or mucus area an increase in the expression or level of at least one intestinal surface area marker protein. Methods for using such supplements are also disclosed.
-
-